Inhibitory effect of fenofibrate on angiotensin II -induced toll-like receptor 4 expression, myeloperoxidase activity and expression in RAW264.7 cells

Yaoxue Xuebao

Volumn 44, Issue 5, 2009, Pages 462-467

  Ji, Yuan Yuan ^a   Wang, Zhi Dong ^a   Liu, Jun Tian ^a   Liu, Na ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Angiotensin II; Fenofibrate; Myeloperoxidase; Toll like receptor 4

Indexed keywords

ANGIOTENSIN II; FENOFIBRATE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOPEROXIDASE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTILIPEMIC AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PEROXIDASE; PROCETOFEN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 67650973797     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity [J]. Nat Immunol, 2001, 2: 675-680. (Pubitemid 32747155)
2. Akira S, Takeda K. Toll-like receptors signaling [J]. Nat Immunol, 2004,4:499-511.
3. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture [J]. Arterioscler Thromb Vasc Biol, 2007, 27: 15-26. (Pubitemid 46360377)
4. Fruchart JC, Duriez P, Staels B. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis [J]. Curr Opin Lipidol, 1999, 10: 245-257. (Pubitemid 29405915)
5. Gervois P, Kleemann R, Pilon A, et al. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferators activated receptor-alpha activator fenofibrate [J]. J Biol Chem, 2004, 279: 16154-16160. (Pubitemid 38509307)
6. Wang ZH, Luo F, Liu XM. Effect of PPARγ agonist rosiglitazone on regression of the atherosclerotic plaques in rabbits [J]. Acta Pharm Sin, 2005, 40: 1051-1053. (Pubitemid 43028232)
7. Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2004, 24: 2227-2236. (Pubitemid 39658022)
8. Liu HQ, Zhang XM, Wei XB. Protective effect of losartan on bovine cerebral microvessel endothelial cell injury induced by angiotensin II in culture [J]. Acta Pharm Sin, 2003, 38: 5-9.
9. Ji YY, Wang ZD, Liu JT, et al. Angiotensin II induces toll-like receptor 4 expression and myeloperoxidase activity in RAW264.7 cells [J]. Chin J Cell Mol Immunol, 2008, 24: 1037-1039.
10. Marx N, Duez H, Fruchart JC, et al. Peroxisome proliferator-activated receptors and atherogenesis regulators of gene expression in vascular cells [J]. Circ Res, 2004, 94: 1168-1178. (Pubitemid 38656403)
11. Koh K, Ahn JY, Jin DK, et al. Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia [J]. Int J Cardiol, 2004, 97: 239-244. (Pubitemid 39286842)
12. Touyz RM, Schiffrin EL. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications [J]. Vascul Pharmacol, 2006, 45: 19-28. (Pubitemid 43963482)
13. Brennan ML, Penn MS, VanLente F, et al. Prognostic value of myeloper-oxidase in patients with chest pain [J]. N Engl J Med, 2003, 349: 1595-1604. (Pubitemid 37288567)